TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05523466

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture Active
Description: Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Active acupuncture using specific Traditional Chinese Acupuncture points: E36, BP6, F3, IG4, for 20 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture Active
Description: Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Active acupuncture using specific Traditional Chinese Acupuncture points: E36, BP6, F3, IG4, for 20 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture Sham
Description: Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Sham acupuncture using sham points (points not recognized as Acupuncture points), with the duration of 20 minutes

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture Sham
Description: Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Sham acupuncture using sham points (points not recognized as Acupuncture points), with the duration of 20 minutes
Study: NCT06019806

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: POSTURAL CORRECTION four exercises
Description: The program will involve four exercises, including two strengthening exercises and two stretching exercises.~1. Chin tuck (deep cervical flexor)~2. Strengthening shoulder retractors~3. Sternocleidomastoid muscle stretch~4. Pectoralis stretch Participants will be instructed to perform three sets of 12 repetitions for the strengthening exercises, with a 30-second rest period allotted between each set. For the stretching exercises, participants will be instructed to hold each stretch for 30 seconds, with a 30-second rest period allotted between each exercise The experimental group will also receive postural Correction education

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: postural Correction education with a manuscript
Description: The control group would receive postural Correction education and they would be provided with a manuscript. They would be then guided to follow these guidelines as a home plan for four weeks. At the end of the Fourth week, they would be assessed.
Study: NCT05551052

Intervention type: DIAGNOSTIC_TEST
Intervention: Next-Gen CRC Screening Test
Description: The Next-Gen CRC Screening Test is a blood-based screening test for detection of CRC.
Study: NCT04971252

Intervention type: DIAGNOSTIC_TEST
Intervention: Hematologic tests for patients with diabetes mellitus and chronic kidney disease
Description: Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease

Intervention type: DIAGNOSTIC_TEST
Intervention: Hematologic tests for patients with diabetes mellitus and chronic kidney disease
Description: Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease

Intervention type: DIAGNOSTIC_TEST
Intervention: Hematologic tests for patients with diabetes mellitus and chronic kidney disease
Description: Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease
Study: NCT05285306

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PEACE Program
Description: This pilot will consist of 3 individual telemedicine sessions to teach cognitive behavioral coping skills and provide education related to gynecologic cancer surveillance and psychological distress.
Study: NCT05117203

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WB-EMS (Whole body electrostimulation)
Description: Application of physical exercise and electrical stimulation on the abdominal muscles through the WB-EMS during 20 minutes training session with specific exercise (CORE)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EMS
Description: Application of physical exercise and electrical stimulation on the abdominal muscles through the EMS during 20 minutes training session with specific exercise (CORE)

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: WB-EMS off
Description: Application of physical exercise without electrical stimulation on the abdominal muscles through the WB-EMS off during a 20 minutes training session with specific exercise (CORE).
Study: NCT05787106

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cyberball task
Description: The game consists of ball throws between animated characters lasting about 50 throws. In the rejection condition, after 2 or 3 throws, the participant no longer receives the ball (no more passes). In the control conditions (all included), the participant receives the ball as often as the others.
Study: NCT05583032

Intervention type: DEVICE
Intervention: ScanNav Anatomy PNB
Description: AI-powered device that highlights anatomy of interest during ultrasound scans.
Study: NCT03943849

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Particulate bone graft
Description: Creos allo.gain allogenic bone particulate mineralized cortical bone will be hydrated and placed in the extraction socket.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Particulate bone graft
Description: Creos allo.gain allogenic bone particulate mineralized cortical bone will be hydrated and placed in the extraction socket.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autogenous dental pulp tissue
Description: Dental pulp will be isolated from teeth extracted for non-periodontal reasons chairside, mixed with hydrated particulate bone graft, and then placed in the extraction socket.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resorbable collagen membrane
Description: After placement of particulate bone graft or particulate bone graft plus autogenous dental pulp tissue, socket will be covered by a resorbable collagen membrane and sutured.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resorbable collagen membrane
Description: After placement of particulate bone graft or particulate bone graft plus autogenous dental pulp tissue, socket will be covered by a resorbable collagen membrane and sutured.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Suture
Description: Resorbable or non-resorbable suture material
Study: NCT04717687

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Irreversible electroporation
Description: Device: NanoKnife The aim of the treatment is to surround the tumour with two to six needles and to deliver a very high voltage current (3000 volts in 70 to 80 microseconds pulses) by a generator synchronized with an electrocardiogram.
Study: NCT05963113

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pharyngeal Swallowing Exercises
Description: 12-weeks of proactive pharyngeal swallowing exercises conducted 5 times per week. The exercise program will include the following four exercises: effortful saliva swallows, tongue-hold swallows, effortful pitch glides and posterior lingual resistance. Each exercise set will include 10 repetitions of each exercise (40 reps per set). The number of sets will be gradually increased as tolerance builds.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharyngeal Swallowing Exercises
Description: 12-weeks of proactive pharyngeal swallowing exercises conducted 5 times per week. The exercise program will include the following four exercises: effortful saliva swallows, tongue-hold swallows, effortful pitch glides and posterior lingual resistance. Each exercise set will include 10 repetitions of each exercise (40 reps per set). The number of sets will be gradually increased as tolerance builds.
Study: NCT05553886

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
Description: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
Description: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
Study: NCT04422951

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wise interventions -- values self-affirmation and growth mindset -- plus usual care behavioral treatment
Description: Addition of two wise wise social psychological interventions-growth mindset and self-affirmation-to a 6-month usual care behavioral intervention for weight control in children with obesity

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education plus usual care behavioral treatment
Description: 6-month health education plus usual care behavioral intervention for weight control in children with obesity
Study: NCT05577351

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RapidPulseTM Aspiration System
Description: The RapidPulseTM Aspiration System paired with a single-use, disposable tubing set specific for use with the RapidPulseTM Aspiration System
Study: NCT06462391

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Acceptance and Commitment Therapy (ACT) Group
Description: Psychotherapy group (delivered virtually)
Study: NCT04781946

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic pneumatic balloon dilation
Description: Using endoscopy, pneumatic balloon dilation may be used to treat stenosis of the gastric sleeve.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gastric peroral endoscopic myotomy (G-POEM)
Description: Gastric per-oral endoscopic myotomy (G-POEM) is a recent innovation offering a minimally invasive endoscopic approach. G-POEM allows for the creation of a tunnel and subsequent myotomy from the gastric cardia to the gastric pylorus.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Description: The Roux-en-Y gastric bypass is a type of weight-loss surgery that involves creating a small pouch from the stomach and connecting the newly created pouch directly to the small intestine.
Study: NCT05220020

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TACE(Transcatheter arterial chemoembolization)
Description: Hepatic arterial chemoembolization treatment

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TACE(Transcatheter arterial chemoembolization)
Description: Hepatic arterial chemoembolization treatment

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lenvatinib
Description: Experimental group(Synchronous treatment group): the first course of TACE treatment was started after 2-3 weeks Lenvatinib treatment.Control group:(Sequential treatment group)patients with uncontrolled TACE progression after TACE treatment were sequentially treated with Lenvatinib.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Experimental group(Synchronous treatment group): the first course of TACE treatment was started after 2-3 weeks Lenvatinib treatment.Control group:(Sequential treatment group)patients with uncontrolled TACE progression after TACE treatment were sequentially treated with Lenvatinib.
Study: NCT05963113

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein Supplementation
Description: 12-week supply of the commercially-available Premier Protein Clear ® High Protein (20 grams of protein and 90 calories per 16.9 oz. drink). Participants will be asked to consume one drink per day for the 12-week intervention period.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRI
Description: Participants will be scanned using a 3T MRI scanner and a 16-channel phased array neck coil.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI
Description: Participants will be scanned using a 3T MRI scanner and a 16-channel phased array neck coil.
Study: NCT06505577

Intervention type: OTHER
Intervention: No additional intervention
Description: All patients are scheduled to undergo standard breast surgery as part of their routine clinical care. No additional interventions are administered specifically for this study.
Study: NCT05645445

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: patients who include intervention gruop during the ESWL process, patients will be shown videos with virtual reality glasses, which include nature and landscapes, giving people a feeling of comfort and peace, and making them feel like they are inside.
Study: NCT03943849

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suture
Description: Resorbable or non-resorbable suture material
Study: NCT06500195

Intervention type: PROCEDURE
Intervention: implantation of the hybrid instrumentation system
Description: Surgery corrections were performed using the hybrid instrumentation system (screws and bands).
Study: NCT04804202

Intervention type: OTHER
Group type: OTHER
Intervention: Bicycling with and without virtual reality
Description: In one session: Exercise intensity and enjoyment are measured while participants bicycle in a virtual compared to non-virtual environment. Cycling takes places in two modes continous and interval. In a second session exercise intensity and enjoyment are compared during bicycling with virtual reality presented in two different ways.
Study: NCT04852809

Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study

Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study
Study: NCT05994690

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Intervention Rc
Description: 3 consolidation courses (HAM + HA3E + FLA)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Investigational Intervention Rc
Description: 2 consolidation courses (HAM + FLA)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Intervention Ri
Description: No addition of GO to first induction course

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Investigational Intervention Ri
Description: Addition of GO to first induction course
Study: NCT05771948

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: CCoat
Description: CCoat is a new intra-articular (IA) injectable joint lubricant for patients suffering from joint pain developed by Liposphere LTD. CCoat is a liposomal boundary lubricant which coats the cartilage surface and protects it from further damage and degradation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CCoat
Description: CCoat is a new intra-articular (IA) injectable joint lubricant for patients suffering from joint pain developed by Liposphere LTD. CCoat is a liposomal boundary lubricant which coats the cartilage surface and protects it from further damage and degradation.
Study: NCT06455813

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bisacodyl
Description: The patients' stool frequency, degree of constipation and side effects of the medication as well as pain, nausea and flatulence are scored once a day using the Bristol Stool Scale, Verbal Rank Scale and Patient Assessment of Constipation symptoms Questionnaire. If the first defecation has not occurred 72 hours after the end of the operation, the patients in all three groups are transferred to treatment with peristaltic-promoting agents
Study: NCT05635474

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bacillus Coagulans
Description: Bacillus coagulans is a Gram-positive bacterium belonging to the genus Bacillus and does not exist in the intestinal microbiota, because it has the characteristics of spore production and lactobacillus lactic acid production, and has the ability to maintain the health of intestinal bacteria, acid and alkali resistance, With the advantages of high temperature resistance and high stability, it is currently one of the commonly used probiotic strains.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo was also administered in the form of capsules consisting of maltodextrin, silicon dioxide, and magnesium stearate.
Study: NCT05678452

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HOLEP for treating BPH
Description: HoLEP will be performed using 100W Versapulse, Luminis Inc., with 2J/25Hz for LP-HoLEP and 2J/50Hz for HP-HoLEP.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HOLEP for treating BPH
Description: HoLEP will be performed using 100W Versapulse, Luminis Inc., with 2J/25Hz for LP-HoLEP and 2J/50Hz for HP-HoLEP.
Study: NCT05928416

Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva sample
Description: During the inclusion visit :~* a neurological examination is taken~* a saliva sample is taken

Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva sample
Description: During the inclusion visit :~* a saliva sample is taken
Study: NCT06455813

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Macrogol 3350 and electrolytes
Description: The patients' stool frequency, degree of constipation and side effects of the medication as well as pain, nausea and flatulence are scored once a day using the Bristol Stool Scale, Verbal Rank Scale and Patient Assessment of Constipation symptoms Questionnaire. If the first defecation has not occurred 72 hours after the end of the operation, the patients in all three groups are transferred to treatment with peristaltic-promoting agents

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: A combination of macrogol 3350 and electrolytes and bisacodyl
Description: The patients' stool frequency, degree of constipation and side effects of the medication as well as pain, nausea and flatulence are scored once a day using the Bristol Stool Scale, Verbal Rank Scale and Patient Assessment of Constipation symptoms Questionnaire. If the first defecation has not occurred 72 hours after the end of the operation, the patients in all three groups are transferred to treatment with peristaltic-promoting agents
Study: NCT06253806

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Stellate Ganglion Block
Description: The stellate ganglion will be identified using ultrasound guidance, and after negative aspiration, 6-8 mL of 1% mepivacaine will be injected near the stellate ganglion.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Sham Injection
Description: The stellate ganglion will be identified using ultrasound guidance, and after negative aspiration, 6-8 mL of 0.9% saline will be injected near the stellate ganglion.
Study: NCT05870618

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: vaccinate with DTap
Description: vaccinate with DTap

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: vaccinate with DT
Description: vaccinate with DT
Study: NCT04883515

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral glutamine supplementation
Description: patient will receive oral glutamine supplementation 10 g Ter In Die during 8 weeks
Study: NCT06141343

Intervention type: DIETARY_SUPPLEMENT
Intervention: Veillonella atypica FB0054
Description: Veillonella contains Veillonella atypica FB0054 as the active ingredient with microcrystalline cellulose and hypromellose as excipients. The two doses are 15 billion cfu (high dose) and 7.5 billion cfu (low dose). Placebo capsules contain microcrystalline cellulose and hypromellose. Both Veillonella and placebo are encapsulated in acid-resistant capsules to improve delivery to the large intestine, which participants will take orally at home on a daily basis for four weeks.

Intervention type: OTHER
Intervention: Placebo
Description: Placebo will be given as the non-active study control
Study: NCT05511311

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resistance Training
Description: Resistance training developed by the researcher (SCR-RSCM) for 12 weeks

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Therapy
Description: Standard therapy for 12 weeks
Study: NCT05847829

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: T-REEX algorithm
Description: Phase locked transcranial stimulation.
Study: NCT04883515

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral protein powder supplementation
Description: patient will receive oral protein powder supplementation10 g Ter In Die during 8 weeks

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Insulin-resistance evaluation
Description: Homeostasic model assessment of insulin resistance test will be performed at baseline, Week 8 and Week 16

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Insulin-resistance evaluation
Description: Homeostasic model assessment of insulin resistance test will be performed at baseline, Week 8 and Week 16

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Functional intestinal disorders evaluation
Description: Functional intestinal disorders will be measured by the IBS severity score and feces consistency by Bristol scale at baseline, Week 8 and Week 16

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Functional intestinal disorders evaluation
Description: Functional intestinal disorders will be measured by the IBS severity score and feces consistency by Bristol scale at baseline, Week 8 and Week 16
Study: NCT04715867

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabix-VC
Description: Rabix-VC will be locally manufactured by Incepta Vaccine Ltd

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabix-VC
Description: Rabix-VC will be locally manufactured by Incepta Vaccine Ltd

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabix-VC
Description: Rabix-VC will be locally manufactured by Incepta Vaccine Ltd

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabix-VC
Description: Rabix-VC will be locally manufactured by Incepta Vaccine Ltd
Study: NCT06173726

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BST02 Injection
Description: The TIL used for tumor tissue surgical sampling of qualified subjects was used to prepare BST02 injection, and the subjects who successfully received the surgical sampling were considered to be enrolled.~In the study process, cell transfusions were recorded as day 0 of the study. On the 3rd day (D-3) before infusion of BST02 injection, it is necessary to receive eluvial pretreatment. Considering that this product is unmodified autologous T lymphocytes, previous studies have shown that low-intensity cyclophosphamide can stimulate their proliferation in vivo. Therefore, the cyclophosphamide (Cy) single-drug regimen is recommended: Cy 250mg\~1.5g/m2, a single intravenous infusion